Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen

To improve the prognosis of glioblastoma, we developed an adjuvant treatment directed to a neglected aspect of glioblastoma growth, the contribution of nonmalignant monocyte lineage cells (MLCs) (monocyte, macrophage, microglia, dendritic cells) that infiltrated a main tumor mass. These nonmalignant...

Descripción completa

Detalles Bibliográficos
Autores principales: Salacz, Michael E, Kast, Richard E, Saki, Najmaldin, Brüning, Ansgar, Karpel-Massler, Georg, Halatsch, Marc-Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854261/
https://www.ncbi.nlm.nih.gov/pubmed/27175087
http://dx.doi.org/10.2147/OTT.S100407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854261/
https://www.ncbi.nlm.nih.gov/pubmed/27175087
http://dx.doi.org/10.2147/OTT.S100407

Ejemplares similares